XHP is committed to providing timely access to biomedical research. JCTH(IF: 4.2) | ERHM | JERP | JCTP | CSP | FIM | GE | JTG | Oncology Advances | NSSS

Texas, USA
Joined June 2016
🔬 Thailand’s hepatitis response can draw practical lessons from China while adapting to local gaps in screening, linkage to care and prevention. @WHOThailand #Hepatitis #PublicHealth 🔗 xiahepublishing.com/2703-173…
3
64
🔬 Chinese pediatric low-grade glioma guidance is moving from consensus toward molecular precision. This interpretation highlights how to apply it in practice. @ISPNOnline #PediatricGlioma #PrecisionOncology 🔗 xiahepublishing.com/3067-615…
47
🔬 LDL desialylation may be an early atherogenic trigger. Could sialidase inhibition interrupt lipid accumulation and vascular inflammation? @escardio #LDL #Atherosclerosis 🔗 xiahepublishing.com/1555-388…
1
84
🔬 CRRT success depends on the prescription details: dose delivery, anticoagulation, fluid balance, electrolytes and continuous monitoring all matter. @IntensiveCareMed #CRRT #CriticalCare 🔗 xiahepublishing.com/2590-343…
1
47
🔬 Organic co-solvents are not inert details in drug–target studies. Solvent choice can reshape binding results, reproducibility and interpretation. @bpspubs #Pharmacology #DrugDiscovery 🔗 xiahepublishing.com/2572-550…
1
32